Targeted treatment of advanced NRAS-mutated melanoma

Oncotarget. 2017 Sep 29;8(49):84616-84617. doi: 10.18632/oncotarget.21388. eCollection 2017 Oct 17.

Authors

Peter Koelblinger¹, Reinhard Dummer¹

Affiliation

¹ Reinhard Dummer: Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.

No abstract available

Keywords: MEK-inhibitor; NEMO; NRAS; binimetinib; melanoma.

Publication types

Editorial